These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3263710)

  • 1. Further evidence of von Willebrand factor involvement in thrombotic thrombocytopenia purpura.
    Chediak J; Eldridge J; Bergmann F; Sobel D; Baron J; Maxey B; Telfer MC
    Thromb Haemost; 1988 Aug; 60(1):13-7. PubMed ID: 3263710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
    Tatewaki W
    Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
    Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura].
    Saitoh M; Wada H; Tanigawa M; Tamaki S; Masuya M; Minami N; Deguchi K; Shirakawa S; Tatewaki W; Takahashi H
    Rinsho Ketsueki; 1991 Sep; 32(9):1006-8. PubMed ID: 1942536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombotic thrombocytopenic purpura which was effectively treated by plasma exchange therapy--involvement of vWF and endothelial cell injury].
    Tanaka H; Kusumi S; Takemoto M; Maehama S; Fujimura K; Kuramoto A; Ninomiya M; Morio K; Okuhara T
    Rinsho Ketsueki; 1989 Dec; 30(12):2205-9. PubMed ID: 2621804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura.
    Lian EC; Siddiqui FA
    Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Pereira A; Monteagudo J; Bono A; Lopez-Guillermo A; Ordinas A
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):783-6. PubMed ID: 8292728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
    Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
    Moake JL
    Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
    Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
    Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of von Willebrand factor in pre-eclampsia.
    Bergmann F; Rotmensch S; Rosenzweig B; How H; Chediak J
    Thromb Haemost; 1991 Nov; 66(5):525-8. PubMed ID: 1803615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.